Comparison of Cavaterm endometrial ablation Vs. hysteroscopic endometrial ablation in treatment of abnormal uterine beeding
Phase 3
- Conditions
- Abnormla Uterine Bleeding.Other abnormal uterine and vaginal bleeding
- Registration Number
- IRCT20220210053986N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Non nullipar women in the age range between 35-55
Abnormal uterine bleeding (AUB)
Lack of proper response to medical treatment
Not trying to conceeve more
Unwillingness to hystrectomy
Exclusion Criteria
Malignancy which confirmed in pathology (Curretage or piple biopsy sample)
Grade 0 & 1 submucosal myoma in sonography
Uterine cavity distortion
Uterine size > 20 weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amenorhea incidence. Timepoint: Months 3,6 and 12 after surgery. Method of measurement: Clinical history.
- Secondary Outcome Measures
Name Time Method eed to hystrectomy. Timepoint: Months 3, 6 and 12 after surgery. Method of measurement: Clinical history.;Menstraul bleeding severity. Timepoint: Months 3,6 and 12 after surgery. Method of measurement: Days of menstraul bleeding and number of used menstrual pads.;Satisfaction after surgery. Timepoint: Months 3,6 and 12 after surgery. Method of measurement: Likert scale.